Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation

Adjuvants are key components in vaccines, they help in reducing the required antigen dose but also modulate the phenotype of the induced immune response. We previously showed that GPI-0100, a saponin-derived adjuvant, enhances antigen-specific mucosal and systemic antibody responses to influenza sub...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Vaccines (Basel)
Päätekijät: Patil, Harshad P., Herrera Rodriguez, José, de Vries-Idema, Jacqueline, Meijerhof, Tjarko, Frijlink, Henderik W., Hinrichs, Wouter L. J., Huckriede, Anke
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620550/
https://ncbi.nlm.nih.gov/pubmed/28749414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines5030019
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia